The trajectory of Katie Jacobs Stanton’s career serves as a blueprint for the modern intersection of big tech, public service, and specialized venture capital. While many investors enter the healthcare sector through medical or academic backgrounds, Stanton’s path was forged through the crucible of Silicon Valley’s hyper-growth era and the highest levels of federal digital […]
The traditional framework of chronic disease management in the United States is currently facing a critical inflection point as providers and policymakers grapple with a fundamental disconnect between clinical interventions and patient reality. For decades, the healthcare system has been architected to treat chronic conditions almost exclusively within the confines of the exam room, despite […]
Flourish Care, a Boston-based maternal healthcare platform specializing in community-based doula support, has successfully closed a $5.7 million seed funding round. This capital infusion is earmarked for the expansion of the company’s hybrid care model, which integrates in-person and virtual doula services into traditional clinical workflows. The funding round was led by Zeal Capital Partners, […]
The U.S. Food and Drug Administration (FDA) has granted approval to Icotyde (icotrokinra), a novel once-daily oral peptide developed by Johnson & Johnson, for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older who weigh at least 40 kg (88 pounds). This regulatory milestone marks a significant shift […]
The integration of high-level data strategy into the high-stakes environment of emergency medicine represents one of the most significant frontiers in modern healthcare. As the medical industry shifts toward a more connected ecosystem, the disparity between administrative data goals and the practical needs of frontline clinicians remains a central challenge. Two prominent industry executives, Jason […]
The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Aldeyra Therapeutics regarding its New Drug Application (NDA) for reproxalap, a novel eye drop intended for the treatment of the signs and symptoms of dry eye disease. This decision marks the third regulatory setback for the Lexington, Massachusetts-based biotechnology company […]
The healthcare industry is currently navigating a period of profound financial restructuring as stakeholders grapple with the dual pressures of rising costs and heightened consumer expectations. According to a comprehensive six-part research series commissioned by Zelis and conducted by Datos Insights, the financial dimension of healthcare has become just as critical as clinical outcomes in […]
In a significant development for the healthcare technology sector, GuardDog Telehealth has formally admitted to misrepresenting its business operations to gain unauthorized access to patient medical records. This admission marks the first major concession in a high-stakes legal battle led by Epic Systems, the nation’s largest electronic health record (EHR) vendor, against a network of […]
The pharmaceutical and biotechnology sectors are currently undergoing a fundamental transformation driven by the integration of Real-World Evidence (RWE) and Machine Learning (ML). As of late 2024, RWE has transitioned from a supplementary data source to a primary pillar of the drug development lifecycle, appearing in approximately 70 percent of all new drug and biologic […]
The annual SXSW Festival in Austin, Texas, known for its intersection of technology, culture, and business, became the backdrop for a sharp critique of the burgeoning direct-to-consumer healthcare industry. On a sweltering afternoon with temperatures exceeding 95 degrees, Mark Cuban, the billionaire co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of eMed Population Health, […]
